Menu

Image of the Day: Warp Speed

Snipefish use a recoil mechanism to feed rapidly.

Jul 5, 2018
Sukanya Charuchandra
This video, 66 times slower than real life, shows a snipefish (Macroramphosus scolopax) feeding strike. 
SARAH J. LONGO

ABOVE: Half the head of a snipefish (Macroramphosus scolopax) has been digitally dissected in this micro-CT scan reconstruction to reveal the internal structures. SARAH J. LONGO

Snipefish (Macroramphosus scolopax), like their seahorse relatives, employ a spring mechanism for feeding, according to research published yesterday (July 4) in Proceedings of the Royal Society B: Biological Sciences. The fish speedily rotate their trumpet-like snouts using stored elastic energy and suck prey into their distended mouths in 2 ms. The researchers used high-speed videos that were slowed down to observe the feeding strike motion.

S.J. Longo et al., “Extremely fast feeding strikes are powered by elastic recoil in a seahorse relative, the snipefish, Macroramphosus scolopax,” Proc R Soc B, doi:10.1098/rspb.2018.1078, 2018.

This is an animated dissection of a snipefish (Macroramphosus scolopax) created from a micro-CT scan. 
SARAH J. LONGO 


February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.